Search

everythinglearnresearchcommunity

for

Search:↓

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

A new compound shows promise as a topical treatment for hair loss.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

JAK inhibitors show promise for treating various skin diseases.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Storing hair follicles in a special buffer with certain inhibitors can increase hair growth and improve transplant results.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

EGFR inhibitors can cause yellowish skin eruptions.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

JAK inhibitors offer new hope for treating severe alopecia areata.